Abstract: A compound is represented by a formula (20) below.

Abstract: A compound represented by the following formula (1A) or (1B): (the symbols in the formulae (1A) and (1B) have the same meaning as defined in the specification), an organic electroluminescent device containing the compound, and an electronic device including the organic electroluminescent device.

Abstract: A compound having anticancer activity, or a pharmaceutically acceptable salt thereof is provided. Used is a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: (wherein, L1 and L2 are the same or different and each represents a group represented by one formula selected from the group consisting of formulas (A) to (F), and S represents a group represented by one formula selected from the group consisting of formulas (S1) to (S18)).

Abstract: A compound represented by the following formula (A1) (X1 is O or S; two or more of Y1, Y2, and Y3 are N; and Ar1 is an aryl group including 6 to 50 ring carbon atoms, comprising a benzene ring having at least substituent Ar2 at the ortho-position; Ar2 is an aryl group; and Ar3 is a predetermined group).

Abstract: A compound represented by the following formula (1):

Abstract: An organic electroluminescence device includes: an anode; an emitting layer; and a cathode, the emitting layer containing a first material, a second material and a third material, the first material being a fluorescent material, the second material being a delayed fluorescent material, the third material having a singlet energy larger than a singlet energy of the second material.

Abstract: An organic electroluminescence device includes an anode, an emitting layer, and a cathode. The emitting layer contains a delayed fluorescent first compound, a fluorescent second compound, and a third compound represented by Cz-Az. The second compound emits light with a main peak wavelength ranging from 430 nm to 540 nm. Az is a cyclic structure selected from the group consisting of a substituted or unsubstituted pyridine ring, a substituted or unsubstituted pyrimidine ring, a substituted or unsubstituted triazine ring, and a substituted or unsubstituted pyrazine ring. Cz is represented by a formula (3B) below.

Abstract: An organic electroluminescence device having a cathode; an anode; and an emitting layer disposed between the cathode, wherein a first layer in an electron-transporting zone disposed between the emitting layer and the cathode contains a first compound and a second compound, the electron mobility ?1 of the first compound is 1.0×10?5 cm2/Vs or lower, and the second compound is one or more selected from the group consisting of compounds represented by each of the following formulas (11), (12), and (13), provided that the first compound and the second compound are different compounds.

Abstract: The mask of the present disclosure is adapted to be worn on a face including a main body that covers at least a portion of the face, and the main body includes a resin film having air permeability through the thickness thereof. The resin film is a non-porous film having through holes extending through the thickness of the film. The diameter of the through holes is 0.01 ?m or more and 30 ?m or less. The density of the through holes in the resin film is 10 holes/cm2 or more and 1×108 holes/cm2 or less. The mask of the present disclosure is completely different in structure from conventional masks, has high flexibility in the design of various properties such as shielding ability, air permeability, transparency, and sound permeability, and is capable, for example, of exhibiting high shielding ability, high air permeability, high transparency, and high sound permeability.

Abstract: The compounds represented by formula (1): wherein Ar1, Ar2, m, n, L, R, are R1 to R4 are as defined in the description, provides organic electroluminescence devices having device performance further improved.

Abstract: The present invention provides a BET (protein) degrader, specifically a BET degrader containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof: wherein L1 and L2 are the same or different and each represents a small molecular ligand for BET protein, and S represents a group represented by a formula selected from the group consisting of formulas (S1) to (S18).

Abstract: A compound is represented by a formula (1) below, in which k is an integer of 0 or more, m is an integer of 1 or more, n is an integer of 2 or more. L is a substituted or unsubstituted aromatic hydrocarbon ring having 6 to 30 ring carbon atoms, CN is a cyano group, and D1 and D2 are each independently represented by one of a formula (2), a formula (3) and formula (3x) below, D1 and D2 being optionally mutually the same or different.

Abstract: To provide a compound that further improves the capability of an organic EL device, an organic EL device having a further improved device capability, and an electronic device including the organic EL device. A compound represented by the following formula (1) (wherein *p, *q, *r, *s, *b, *a, R1, R2, R11 to R18, L, and R31 to R35 are defined in the description), an organic electroluminescent device containing the compound, and an electronic device including the organic electroluminescent device.

Abstract: An organic electroluminescence device includes an anode, an emitting layer, and a cathode. The emitting layer contains a delayed fluorescent first compound, a fluorescent second compound, and a third compound represented by Cz-Az. The second compound emits light with a main peak wavelength ranging from 430 nm to 540 nm. Az is a cyclic structure selected from the group consisting of a substituted or unsubstituted pyridine ring, a substituted or unsubstituted pyrimidine ring, a substituted or unsubstituted triazine ring, and a substituted or unsubstituted pyrazine ring. Cz is represented by a formula (3B) below.

Abstract: The compounds represented by formula (1): wherein X1, X2, Y1 to Y3, L, *a, R1 to R9, R11 to R18, and R21 to R27 are as defined in the description, provides organic electroluminescence devices having device performance further improved.

Abstract: Provided is a compound represented by a formula (1). In the formula (1): X1 to X5 each independently represent a nitrogen atom or CR10; two or more of X1 to X5 are nitrogen atoms; Y1 to Y5 each independently represent a nitrogen atom or CR20; one or more of Y1 to Y5 are nitrogen atoms; R10, R20, and R5 to R7 forming neither a monocyclic ring nor a fused ring, and R8 and R9 each independently represent a hydrogen atom, an aryl group, a heterocyclic group, or the like; a represents 0, 1, 2, or 3; b represents 0, 1, 2, or 3; and L1 and L2 each independently represent a single bond, an arylene group, a divalent heterocyclic group, or the like.

Abstract: A compound represented by the following formula (1): wherein R1 to R14, L1 to L3, p, q, r, n, and X1 are defined in the description.

Abstract: Provided are: a compound capable of further improving the performance of organic EL devices, an organic electroluminescent device having more improved device performance, and an electronic apparatus including such an organic electroluminescent device. Precisely provided are: a compound represented by the following formula (1): wherein the symbols are as defined in the description, an organic electroluminescent device containing the compound, and an electronic apparatus including such an organic electroluminescent device.

Abstract: An organic electroluminescence device includes an anode, an emitting layer, and a cathode, in which the emitting layer contains a first compound represented by a formula (1) and a fluorescent second compound. A singlet energy S1(M1) of the first compound is larger than a singlet energy S1(FL) of the fluorescent second compound. A is a group represented by a formula (1b).

Abstract: A compound is represented by a formula (2) below.